| Structure | Chemical Name | CAS | MF |
|
Ethyl 2-nitrilo-3-(3-pyridyl)prop-2-enoate
|
136633-60-8
|
C11H10N2O2
|
|
Pyrrolidine, 1-(fluoroacetyl)-2,5-dimethyl-, (2R-trans)- (9CI)
|
136634-11-2
|
C8H14FNO
|
|
Pyrrolidine, 1-(2-fluoro-3-methyl-1-oxo-4-pentenyl)-2,5-dimethyl-, [2R-[1(2R*,3R*),2alpha,5beta]]- (9CI)
|
136634-12-3
|
C12H20FNO
|
|
Pyrrolidine, 1-(2-fluoro-3-methyl-1-oxopentyl)-2,5-dimethyl-, [2R-[1(2R*,3S*),2alpha,5beta]]- (9CI)
|
136634-13-4
|
C12H22FNO
|
|
Propanedinitrile, (3-oxobutyl)- (9CI)
|
136634-48-5
|
C7H8N2O
|
|
ramorelix
|
136639-71-9
|
C74H95ClN16O18
|
|
Boc-D-MeArg(Tos)-OH
|
136642-84-7
|
C19H30N4O6S
|
|
3-(Bromomethyl)phenoxyacetic acid
|
136645-25-5
|
C9H9BrO3
|
|
Methyl-(3-bromomethyl)phenoxyacetate
|
136645-26-6
|
C10H11BrO3
|
|
Carbamic acid, [(2-propenylamino)thioxomethyl]-, ethyl ester (9CI)
|
136646-36-1
|
C7H12N2O2S
|
|
4-[(Diphenylmethoxy)methyl]-1-[3-(4-methoxyphenyl)propyl]-piperidinehydrochloride
|
136647-02-4
|
C29H35NO2.HCl
|
|
3-((Diphenylmethoxy)methylpiperidine
|
136647-20-6
|
C19H23NO
|
|
4-((Diphenylmethoxy)methyl)piperidine
|
136647-21-7
|
C19H23NO
|
|
3-bromo-5-fluoro-1,1'-biphenyl
|
136649-30-4
|
C12H8BrF
|
|
1,1'-Biphenyl, 3-bromo-5-iodo-
|
136649-44-0
|
C12H8BrI
|
|
Allyl Tris(trimethylsilyl)silane
|
136649-77-9
|
C12H32Si4
|
|
TIS11 protein
|
136653-44-6
|
|
|
|
mry protein
|
136653-49-1
|
|
|
dimyristoylphosphatidylinositol
|
136655-51-1
|
C37H71O13P
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde, 3-ethyl-, (2-endo,3-exo)- (9CI)
|
136655-70-4
|
C10H14O
|
|
Trimethylsilyl 3-(3,4-bis[(trimethylsilyl)oxy]phenyl)-2-[(trimethylsil yl)amino]propanoate
|
136655-95-3
|
C21H43NO4Si4
|
|
Timosaponin BII
|
136656-07-0
|
C45H76O19
|
|
3 4-Di-O-acetyl-6-O-(tert-butyldimethyl&
|
136656-49-0
|
C16H28O6Si
|
|
(R)-1-tert-Butoxy-2-propanol
|
136656-73-0
|
C7H16O2
|
|
(2S)-1-tert-butoxypropan-2-ol
|
136656-76-3
|
C7H16O2
|
|
1-hydroxycarvedilol O-glucuronide
|
136657-37-9
|
C30H34N2O11
|
|
8-hydroxycarvedilol O-glucuronide
|
136657-39-1
|
C30H34N2O11
|
|
3-Hydroxy Pravastatin
|
136657-41-5
|
C23H36O8
|
|
bis[4-(dimethylamino)-3-nitrophenyl]methanone
|
136661-37-5
|
C17H18N4O5
|
|
ALPHA-DEFENSIN-3 (HUMAN)
|
136661-76-2
|
C151H222N44O40S6
|
|
Methyl 2-methyl-1,3-benzoxazole-5-carboxylate
|
136663-21-3
|
C10H9NO3
|
|
6-Benzoxazolecarboxylic acid, 2-Methyl-, Methyl ester
|
136663-23-5
|
C10H9NO3
|
|
(2-Methylbenzo[d]oxazol-5-yl)Methanol
|
136663-38-2
|
C9H9NO2
|
|
(2-Methylbenzo[d]oxazol-6-yl)Methanol
|
136663-40-6
|
C9H9NO2
|
|
(2-Methylbenzoxazol-7-yl)methanol
|
136663-42-8
|
C9H9NO2
|
|
2,4-Bis(trifluoromethyl)toluene
|
136664-96-5
|
C9H6F6
|
|
2-Piperazinemethanamine,5-methyl-(9CI)
|
136665-35-5
|
C6H15N3
|
|
5,7-Octadecadiynoic acid
|
136667-54-4
|
C18H28O2
|
|
Quiflapon
|
136668-42-3
|
C34H35ClN2O3S
|
|
4-Chloroindole
|
136669-25-5
|
|
|
N-bromoacetyl-2-iodo-5-methoxytryptamine
|
136669-49-3
|
C13H14BrIN2O2
|
|
1H-Benzimidazole,2-(2,2-dimethylpropyl)-(9CI)
|
136670-88-7
|
C12H16N2
|
|
GG, 2-Oxoethyl beta-D-glucopyranoside
|
136670-93-4
|
C8H14O7
|
|
3-(azepan-1-yl)propanoic acid hydrochloride
|
136671-92-6
|
C9H18ClNO2
|
|
(1H-Indol-3-yl)-(3-methoxy-phenyl)-methanone
|
136672-25-8
|
C16H13NO2
|
|
N-(5-AMinopentyl) Methotrexate AMide
|
136672-64-5
|
C25H34N10O4
|
|
1-phenylpropan-2-one
|
136675-26-8
|
C9H10O
|
|
N2-Pivaloylguanine
|
136675-82-6
|
C10H13N5O2
|
|
Propanamide, N-(8-bromo-6,9-dihydro-6-oxo-1H-purin-2-yl)-2,2-dimethyl-
|
136675-83-7
|
C10H12BrN5O2
|
|
3',5'-Bis-O-benzoyl-2'-Deoxy-2'-fluoro-4-deoxy-arabinouridine
|
136675-87-1
|
C23H19FN2O6
|
|
2'-arafluorozebularine
|
136675-88-2
|
C9H11FN2O4
|
|
S-(+)-1-[(4-(Dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid hydrate di(trifluoroacetate) salt
|
136676-91-0
|
C33H33F3N4O5
|
|
1,3-Dimethyl-1H-pyrazole-5-carboxamide
|
136678-93-8
|
C6H9N3O
|
|
1H-Pyrazole-3-carboxamide,N,1,5-trimethyl-(9CI)
|
136678-94-9
|
C7H11N3O
|
|
1H-Pyrazole-3-carboxamide,N-hydroxy-1,5-dimethyl-(9CI)
|
136678-99-4
|
C6H9N3O2
|
|
1H-Pyrazole-5-carboxamide,N,1,3-trimethyl-(9CI)
|
136679-01-1
|
C7H11N3O
|
|
1H-Pyrazole-5-carboxamide,N-hydroxy-1,3-dimethyl-(9CI)
|
136679-06-6
|
C6H9N3O2
|
|
phenylalanine 4-hydroxybutyl ester
|
136680-70-1
|
C13H19NO3
|
|
Butanoic acid, 3-oxo-2-[(1-oxopropyl)amino]-, methyl ester
|
136682-44-5
|
C8H13NO4
|
|
CYS7
|
136684-54-3
|
C45H61N7O10S2
|
|
N-cyclohexyl-4-fluoroaniline
|
136684-94-1
|
C12H16FN
|
|
14-debromoaraplysillin I
|
136685-29-5
|
C21H24Br3N3O5
|
|
14-debromoprearaplysillin I
|
136685-30-8
|
C21H24Br3N3O4
|
|
9-deoxygoniopypyrone
|
136685-37-5
|
C13H14O4
|
|
benzyloxycarbonyl-alpha-aminoisobutyryl-glycyl-alpha-aminoisobutyryl-leucyl-alpha-aminoisobutyryl-tert-butyl ester
|
136687-69-9
|
C32H51N5O8
|
|
cdc2(6-20)NH2
|
136688-17-0
|
C77H125N19O22
|
|
Cyclopropane, 1-(1,1-dimethylethoxy)-2-ethynyl-, cis- (9CI)
|
136689-61-7
|
C9H14O
|
|
Cyclopropane, 1-(1,1-dimethylethoxy)-2-ethynyl-, trans- (9CI)
|
136689-65-1
|
C9H14O
|
|
3-(1H-Tetrazol-5-yl)benzaldehyde
|
136689-94-6
|
C8H6N4O
|
|
4(1H)-Pteridinone,2-amino-5,6,7,8-tetrahydro-6-methyl-,(R)-(9CI)
|
136693-01-1
|
C7H11N5O
|
|
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)Methyl]-3-[(1,1-diMethylethyl)thio]-5-hydroxy-α,α-diMethyl-, Methyl ester
|
136694-17-2
|
C25H30ClNO3S
|
|
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)Methyl]-3-[(1,1-diMethylethyl)thio]-α,α-diMethyl-5-(2-quinolinylMethoxy)-, Methyl ester
|
136694-18-3
|
C35H37ClN2O3S
|
|
1H-Indole-2-propanoic acid, 3-[(1,1-dimethylethyl)thio]-5-methoxy-methyl ester
|
136694-54-7
|
C19H27NO3S
|
|
(5S,6Z,8E,10E,14Z)-5-hydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid
|
136696-10-1
|
C20H30O4
|
|
|
NEUROPEPTIDE F
|
136697-70-6
|
|
|
4H-Imidazol-4-one, 5-acetyl-2-amino-1,5-dihydro-1-methyl- (9CI)
|
136700-71-5
|
C6H9N3O2
|
|
1-(2-(4-((5-fluoro-1H-indol-3-yl)methyl)-1-piperidinyl)ethyl)-5,6-dihydro-1H,4H-1,2,5-thiadiazolo(4,3,2-ij)quinoline 2,2-dioxide
|
136701-68-3
|
C25H29FN4O2S
|
|
3-Piperidin-4-ylmethyl-quinoline
|
136701-92-3
|
C15H18N2
|
|
8-Quinolinamine,1,2,5,6-tetrahydro-(9CI)
|
136702-04-0
|
C9H12N2
|
|
Butanoic acid, 3-[[(1,1-diMethylethoxy)carbonyl]aMino]-4-hydroxy-, Methyl ester, (3S)-
|
136703-59-8
|
C10H19NO5
|
|
Hexanoic acid, 3-aMino-5-Methyl-, Methyl ester, (R)-
|
136703-73-6
|
C8H17NO2
|
|
1-benzyl-4-(chloromethyl)piperidine(SALTDATA: HCl)
|
136704-10-4
|
C13H18ClN
|
|
Butanedioic acid, 2-(4-hydroxyphenyl)-, 1,4-diMethyl ester
|
136705-25-4
|
C12H14O5
|
|
(+)-1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane
|
136705-62-9
|
C18H36P2
|
|
1,2-Bis((2R,5R)-2,5-di-i-propylphospholano)ethane, min. 97%
|
136705-63-0
|
C22H44P2
|
|
(-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene
|
136705-64-1
|
C22H36P2
|
|
(+)-1,2-Bis[(2R,5R)-2,5-diisopropylphospholano]benzene
|
136705-65-2
|
C26H44P2
|
|
(3S,6S)-3,6-Octanediol
|
136705-66-3
|
C8H18O2
|
|
1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane(cyclooctadiene)rhodium(I) tetrafluoroborate
|
136705-70-9
|
C26H46P2Rh+
|
|
1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane(cyclooctadiene)rhodium(I) trifluoromethanesulfonate
|
136705-71-0
|
C27H46F3O3P2RhS
|
|
1,2-Bis((2R,5R)-2,5-di-i-propylphospholano)ethane(cyclooctadiene)rhodium(I) tetrafluoroborate
|
136705-72-1
|
C32H64BF4P2Rh+2
|
|
(-)-1,2(2R,5R)-2,5-(Dimethylphospholano)benzene(cyclooctadiene)rhodium(I)trifluoromethanesulfonate
|
136705-75-4
|
C27H40F3O3P2RhS
|
|
(-)-1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene(cyclooctadiene)rhodium(I)trifluoromethanesulfonate
|
136705-77-6
|
C31H48F3O3P2RhS
|
|
2,4,5-trihydroxymethamphetamine
|
136706-32-6
|
C10H15NO3
|
|
2,4,5-trihydroxyamphetamine
|
136706-33-7
|
|
|
6-hydroxy-N-methyl-3,4-methylenedioxyamphetamine
|
136706-34-8
|
C11H15NO3
|
|
(S)-N-Boc-2-(2'-propylenyl)alanine
|
136707-27-2
|
C11H19NO4
|
|
2-[(piperidin-4-yloxy)methyl]pyridine(SALTDATA: FREE)
|
136718-74-6
|
C11H16N2O
|
|
(3-Nitro-pyridin-2-yloxy)-acetic acid ethyl ester
|
136718-78-0
|
C9H10N2O5
|
|
NB598 hydrochloride
|
136719-25-0
|
C27H31NOS2.ClH
|